Related Experiment Video
Updated: Feb 12, 2026

Perspectives on Neuroscience
Published on: July 31, 2007
The Impact of NEAT1 on Inflammatory Responses and Processes in Arthropathic Diseases: Latest Findings and
Suleiman Ibrahim Mohammad1,2, Raed Obaid Saleh3, Hamza Abu Owida4
1Electronic Marketing and Social Media, Economic and Administrative Sciences, Zarqa University, Zarqa, Jordan. dr_sliman@yahoo.com.
Abstract:
Arthropathies are joint-related disorders with diverse etiologies but standard clinical and radiographic features. There is growing evidence that long non-coding RNAs (lncRNAs) play a crucial role in regulating the development and progression of certain diseases. Nuclear-enriched abundant transcript 1 (NEAT1) is one of these lncRNAs. It is common and helps control transcription and epigenetics, especially during inflammation. This narrative review presents current data on NEAT1's role in inflammation and its contribution to the development of arthropathies, including psoriasis, rheumatoid arthritis, osteoarthritis, SLE, Behçet's disease, and hemophilic arthropathy. The research demonstrated that NEAT1 regulates immune cell activity, inflammasome formation, and inflammatory signaling pathways through interactions with miRNAs and transcriptional regulators. The activity, progression, and response to treatment of the disease are all linked to its dysregulated expression. In conclusion, NEAT1 appears to be a significant regulator of inflammation and joint disease, potentially serving as both a therapeutic target and a biomarker for joint-related disorders. More mechanistic and translational studies are needed to better understand how it works and how it might be used in medicine.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Inflammatory Response I: Vascular and Cellular
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

